New rule aimed at curbing graft in hospital drugs
Print Edition
Hospitals have been told to order drugs only from pre-approved suppliers in a move intended to regulate a system rife with corruption.
A State Council circular also says that hospitals should pay distribution fees directly to logistics companies to reduce intermediate links, and it has introduced a “multi-party negotiation mechanism” to formalize price negotiations between hospitals and suppliers.
Bribery is common in the bidding process to supply drugs to Chinese hospitals. Winning firms are often unable to fulfill their contracts. There is also a trend of doctors prescribing unnecessary, expensive drugs to reap profits for hospitals or obtain kickbacks from drug companies.
The State Council is promising harsh punishments for violations of the new process.
China has been cracking down on high prices and corruption in the sector over the past year and in September fined GlaxoSmithKline a record 3 billion yuan (US$489 million) for paying bribes to doctors to use its drugs.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
